We are live on
!
Find out more
GCM
Galibier Capital Management Portfolio holdings
AUM
$300M
1-Year Est. Return
22.03%
This Fund
S&P 500
This Quarter
Est. Return
+8.29%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
–
AUM
$425M
AUM Growth
+$113M
(+36%)
Cap. Flow
+$89.4M
Cap. Flow
% of AUM
21.02%
Top 10 Holdings %
Top 10 Hldgs %
79.58%
Holding
40
New
4
Increased
14
Reduced
10
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$18.5M |
| 2 |
GSK
GSK
|
+$18.1M |
| 3 |
Restaurant Brands International
QSR
|
+$11.6M |
| 4 |
Rogers Communications
RCI
|
+$10.7M |
| 5 |
Nutrien
NTR
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$14.4M |
| 2 |
Emerson Electric
EMR
|
+$2.4M |
| 3 |
Middleby
MIDD
|
+$1.43M |
| 4 |
Visa
V
|
+$499K |
| 5 |
Walt Disney
DIS
|
+$312K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.07% |
| 2 | Materials | 18.7% |
| 3 | Consumer Discretionary | 17.91% |
| 4 | Industrials | 12.93% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cognizant
CTSH
$26B
| $1.04M | 0.25% |
15,004
-616
| -4% | -$40.1K |
|
27
AB InBev
BUD
$165B
| $853K | 0.2% |
15,832
| – | – |
|
28
Unilever
UL
$136B
| $827K | 0.19% |
11,911
| – | – |
|
29
JPMorgan Chase
JPM
$950B
| $802K | 0.19% |
8,331
-400
| -5% | -$39.3K |
|
|
30
Walt Disney
DIS
$181B
| $787K | 0.19% |
6,346
-2,500
| -28% | -$312K |
|
31
Voya Financial
VOYA
$9.19B
| $753K | 0.18% |
15,716
-752
| -5% | -$37K |
|
32
Alphabet (Google) Class C
GOOG
$4.32T
| $711K | 0.17% |
9,680
| – | – |
|
33
Truist Financial
TFC
$64B
| $662K | 0.16% |
17,395
-1,000
| -5% | -$37.7K |
|
34
ING
ING
$102B
| $659K | 0.16% |
93,032
| – | – |
|
35
Colgate-Palmolive
CL
$74.4B
| $617K | 0.15% |
8,000
-2,400
| -23% | -$183K |
|
|
36
Alphabet (Google) Class A
GOOGL
$4.33T
| $561K | 0.13% |
7,660
| – | – |
|
|
37
Visa
V
$677B
| $243K | 0.06% |
1,217
-2,500
| -67% | -$499K |
|
38
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $230K | 0.05% |
+2,736
| New | +$230K |
|
39
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $229K | 0.05% |
+2,199
| New | +$230K |
|
|
40
Middleby
MIDD
$6.08B
| – | – |
-18,168
| Closed | -$1.43M |
|
Similar funds
LIG
LSA
OPPS
FIBT
SFG
FW
SC
AFWM
Galibier Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Galibier Capital Management held 40 positions worth $425M, up 36% from $312M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Galibier Capital Management deployed $89.4M of net new capital in Q3 2020, opening 4 new positions and adding to 14 existing holdings. Its largest new stake was GSK: 360,593 shares worth $17M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Materials and Consumer Discretionary.
On the sell side, the largest reduction was AstraZeneca, an estimated $14.4M trimmed.
- Galibier Capital Management's largest Q3 2020 buy was GSK: 360,593 shares worth $17M.
- Galibier Capital Management added most to Kirkland Lake Gold Ltd Ordinary in Q3 2020, an estimated $18.5M increase.
- Galibier Capital Management's biggest Q3 2020 reduction was AstraZeneca, cutting an estimated $14.4M.
- Galibier Capital Management fully exited Middleby in Q3 2020, selling an estimated $1.43M.
- Galibier Capital Management's ten largest holdings make up 80% of its $425M portfolio in Q3 2020.
- Galibier Capital Management opened 4 new positions and closed 1 in Q3 2020.
- Galibier Capital Management's portfolio value rose 36% quarter-over-quarter to $425M.
Based on Galibier Capital Management's 13F filing for Q3 2020, filed 26 Oct 2020.